tyrosyl-prolyl-leucyl-glycinamide has been researched along with Pregnancy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banks, WA; Harrison, LM; Kastin, AJ; Zadina, JE | 1 |
| Callahan, JF; Fukuda, S; Horowitz, D; King, AG; Pelus, LM | 1 |
| Adinoff, BA; Coy, DH; Kastin, AJ; Zadina, JE | 1 |
3 other study(ies) available for tyrosyl-prolyl-leucyl-glycinamide and Pregnancy
| Article | Year |
|---|---|
Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
Topics: Analgesics; Animals; Animals, Newborn; Behavior, Animal; Blood-Brain Barrier; Body Weight; Endorphins; Eye; Female; Growth; Iodine Radioisotopes; Morphine; MSH Release-Inhibiting Hormone; Nociceptors; Pain Measurement; Pregnancy; Rats | 1993 |
Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
Topics: Animals; Bone Marrow Cells; Cell Division; Dose-Response Relationship, Drug; Female; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Mice; Mice, Inbred C57BL; MSH Release-Inhibiting Hormone; Opioid Peptides; Pregnancy; Receptors, Opioid, mu | 2002 |
Developmental, behavioral, and opiate receptor changes after prenatal or postnatal beta-endorphin, CRF, or Tyr-MIF-1.
Topics: Animals; Behavior, Animal; beta-Endorphin; Body Weight; Brain Chemistry; Corticotropin-Releasing Hormone; Endorphins; Female; Growth; MSH Release-Inhibiting Hormone; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu | 1985 |